Middle East & Africa Colorectal Cancer Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Modality (Diagnosis Type, Therapy Type, and Imaging Type) and End User (Hospitals and Diagnostic & Research Laboratories)
The colorectal cancer market in the Middle East & Africa is expected to grow from US$ 885.81 million in 2022 to US$ 1,076.92 million by 2028; it is estimated to grow at a CAGR of 2.5% from 2022 to 2028.
Numerous benefits offered by generic drugs is among the major factor driving the growth of the Middle East & Africa colorectal cancer market. Generic drugs are alternatives to branded drugs. The pharmacological effects of generic drugs are similar to their branded counterparts. Generic drugs are cost-effective as the manufacturers do not invest in developing and marketing a new drug. After the expiry of a drug patent, other manufacturers apply for FDA approval of a generic intended for its manufacturing and selling. Thus, generic drugs are cheaper than their branded counterparts. Generic drugs have the same dosage, effects and side effects, route of administration, risks, safety, and strength as the original branded drugs.
Generic drugs are important in oncology because some anticancer drugs are only offered as generics. Patients are likely to abandon branded prescriptions associated with their higher prices. Generic drugs for cancer treatment are profitable for manufacturers and patients due to their affordability and efficacy, especially in developing countries in the Middle East & Africa, where the paying capacity of consumers is relatively low. Thus, the preference for generic drugs among consumers and the high adoption of generic drugs for colorectal cancer treatment are fueling the growth of the colorectal cancer market in the region.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Middle East & Africa colorectal cancer market at a substantial CAGR during the forecast period.
Middle East & Africa Colorectal Cancer Market Revenue and Forecast to 2028 (US$ Million)
Middle East & Africa Colorectal Cancer Market Segmentation
The Middle East & Africa colorectal cancer market is segmented into modality, end user, and country. Based on modality, the Middle East & Africa colorectal cancer market is segmented into diagnosis type, therapy type, and imaging type. In 2022, the diagnosis type segment held the largest market share and is expected to register the highest CAGR during the forecast period. Based on end user, the Middle East & Africa colorectal cancer market is bifurcated into hospitals and diagnostic & research laboratories. In 2022, the hospitals segment held a larger market share. Based on country, the Middle East & Africa colorectal cancer market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia held the largest market share in 2022.
Abbott, Amgen Inc., Bruker Corporation, Clinical Genomics Technologies Pty Ltd., EDP Biotech Corporation, Epigenomics AG, F. Hoffmann-La Roche AG, Quest Diagnostics, and VolitionRx Limited are among the leading companies operating in the Middle East & Africa colorectal cancer market.
Reasons to Buy
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa colorectal cancer market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa colorectal cancer market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the colorectal cancer market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution"
- 1. Introduction
- 1.1 Scope of the Study.
- 1.2 The Insight Partners Research Report Guidance.
- 1.3 Market Segmentation
- 1.3.1 MEA Colorectal Cancer Market – By Modality.
- 1.3.2 MEA Colorectal Cancer Market – By End User
- 1.3.3 MEA Colorectal Cancer Market – By Country
- 2. MEA Colorectal Cancer Market – Key Takeaways
- 3. Research Methodology
- 3.1 Coverage
- 3.2 Secondary Research
- 3.3 Primary Research
- 4. MEA Colorectal Cancer– Market Landscape
- 4.1 Overview
- 4.2 MEA PEST Analysis
- 4.3 Expert Opinion
- 5. MEA Colorectal Cancer Market – Key Market Dynamics
- 5.1 Market Drivers
- 5.1.1 Increasing Prevalence of Colorectal Cancer
- 5.1.2 New Product Launches
- 5.1.3 Benefits Offered by Generic Drugs
- 5.2 Market Restraints
- 5.2.1 Pricing Pressure on Drug Manufacturers
- 5.3 Future Trends
- 5.3.1 Inclination Toward Personalized Medicine
- 5.4 Impact Analysis
- 6. MEA Colorectal Cancer Market– MEA Analysis
- 6.1 MEA Colorectal Cancer Market Revenue Forecast and Analysis
- 7. MEA Colorectal Cancer Market Analysis – By Modality
- 7.1 Overview
- 7.2 MEA Colorectal Cancer Market Revenue Share, By Modality 2022 & 2028 (%)
- 7.3 Diagnosis Type
- 7.3.1 Overview
- 7.3.2 Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Immunohistochemistry
- 7.3.3.1 Overview
- 7.3.3.2 Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Stool Test
- 7.3.4.1 Overview
- 7.3.4.2 Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Flexible Sigmoidoscopy
- 7.3.5.1 Overview
- 7.3.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.3.6 Colonoscopy
- 7.3.6.1 Overview
- 7.3.6.2 Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.3.7 CEA Test
- 7.3.7.1 Overview
- 7.3.7.2 CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.3.8 Other Test
- 7.3.8.1 Overview
- 7.3.8.2 Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4 Therapy Type
- 7.4.1 Overview
- 7.4.2 MEA Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Chemotherapy
- 7.4.3.1 Overview
- 7.4.3.2 Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.3.3 Alkylating Agent
- 7.4.3.3.1 Overview
- 7.4.3.3.2 Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.3.4 Antimetabolites
- 7.4.3.4.1 Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.3.5 Others
- 7.4.3.5.1 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Immunotherapy
- 7.4.4.1 Overview
- 7.4.4.2 Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.4.3 Panitumumab.
- 7.4.4.3.1 Overview
- 7.4.4.3.2 Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.4.4 Cetuximab.
- 7.4.4.4.1 Overview
- 7.4.4.4.2 Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.4.5 Bevacizumab
- 7.4.4.5.1 Overview
- 7.4.4.5.2 Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.4.6 Others
- 7.4.4.6.1 Overview
- 7.4.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.5 Chemoprotectant
- 7.4.5.1 Overview
- 7.4.5.2 Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.4.6 Others.
- 7.4.6.1 Overview
- 7.4.6.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.5 Imaging Type
- 7.5.1 Overview
- 7.5.2 MEA Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.5.3 Computed Tomography (CT)
- 7.5.3.1 Overview
- 7.5.3.2 Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.5.4 Magnetic Resonance Imaging (MRI)
- 7.5.4.1 Overview
- 7.5.4.2 Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 7.5.5 Others
- 7.5.5.1 Overview
- 7.5.5.2 Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 8. MEA Colorectal Cancer Market Revenue and Forecast To 2028 – By End User
- 8.1 Overview
- 8.2 MEA Colorectal Cancer Market Revenue Share, By End User 2022 & 2028 (%)
- 8.3 Hospitals
- 8.3.1 Overview
- 8.3.2 Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 8.4 Diagnostic and Research Laboratories.
- 8.4.1 Overview.
- 8.4.2 Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- 9. MEA Colorectal Cancer Market Revenue and Forecast to 2028 – Country Analysis
- 9.1 Overview.
- 9.1.1 MEA Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
- 9.1.1.1 UAE Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)
- 9.1.1.1.1 UAE Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)
- 9.1.1.1.2 UAE: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
- 9.1.1.1.2.1 UAE: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
- 9.1.1.1.2.2 UAE: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
- 9.1.1.1.2.2.1 UAE: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
- 9.1.1.1.2.2.2 UAE: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
- 9.1.1.1.2.3 UAE: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
- 9.1.1.1.3 UAE : Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
- 9.1.1.2 Saudi Arabia Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
- 9.1.1.2.1 Saudi Arabia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)
- 9.1.1.2.2 Saudi Arabia: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
- 9.1.1.2.2.1 Saudi Arabia: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
- 9.1.1.2.2.2 Saudi Arabia: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
- 9.1.1.2.2.2.1 Saudi Arabia: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
- 9.1.1.2.2.2.2 Saudi Arabia: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
- 9.1.1.2.2.3 Saudi Arabia: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
- 9.1.1.2.3 Saudi Arabia: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
- 9.1.1.3 South Africa Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)
- 9.1.1.3.1 South Africa Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)
- 9.1.1.3.2 South Africa: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
- 9.1.1.3.2.1 South Africa: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
- 9.1.1.3.2.2 South Africa: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
- 9.1.1.3.2.2.1 South Africa: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
- 9.1.1.3.2.2.2 South Africa: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
- 9.1.1.3.2.3 South Africa: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
- 9.1.1.3.3 South Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
- 9.1.1.4 Rest of MEA: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
- 9.1.1.4.1 Overview.
- 9.1.1.4.2 Rest of MEA: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
- 9.1.1.4.3 Rest of MEA: Colorectal Cancer Market – Revenue and Forecast to 2028, By Modality (US$ Million)
- 9.1.1.4.3.1 Rest of MEA:: Colorectal Cancer Market, by Diagnosis Type – 2019–2028 (US$ Million)
- 9.1.1.4.3.2 Rest of MEA: Colorectal Cancer Market, by Therapy Type– 2019- 2028 (US$ Million)
- 9.1.1.4.3.2.1 Rest of MEA: Colorectal Cancer Market, by Chemotherapy– 2019- 2028 (US$ Million)
- 9.1.1.4.3.2.2 Rest of MEA: Colorectal Cancer Market, by Immunotherapy– 2019- 2028 (US$ Million)
- 9.1.1.4.3.3 Rest of MEA: Colorectal Cancer Market, by Imaging Type– 2019- 2028 (US$ Million)
- 9.1.1.4.4 Rest of MEA: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
- 10. Colorectal Cancer Market – Industry Landscape
- 10.1 Overview..
- 10.2 Growth Strategies In The Colorectal Cancer Market, 2022-2028.
- 10.3 Organic Developments.
- 10.3.1 Overview..
- 10.3.2 Organic Growth Strategies In The Colorectal Cancer Market, 2022-2028.
- 10.4 Inorganic Developments.
- 10.4.1 Overview..
- 10.4.2 Inorganic Growth Strategies In The Colorectal Cancer Market, 2022-2028.
- 11. Company Profiles
- 11.1 Epigenomics AG..
- 11.1.1 Key Facts.
- 11.1.2 Business Description.
- 11.1.3 Products and Services.
- 11.1.4 Financial Overview..
- 11.1.5 SWOT Analysis.
- 11.1.6 Key Developments.
- 11.2 Abbott
- 11.2.1 Key Facts.
- 11.2.2 Business Description.
- 11.2.3 Products and Services.
- 11.2.4 Financial Overview..
- 11.2.5 SWOT Analysis.
- 11.2.6 Key Developments
- 11.3 Amgen Inc.
- 11.3.1 Key Facts.
- 11.3.2 Business Description.
- 11.3.3 Products and Services.
- 11.3.4 Financial Overview..
- 11.3.5 SWOT Analysis.
- 11.3.6 Key Developments.
- 11.4 F. HOFFMANN-LA ROCHE LTD.
- 11.4.1 Key Facts.
- 11.4.2 Business Description.
- 11.4.3 Products and Services.
- 11.4.4 Financial Overview..
- 11.4.5 SWOT Analysis.
- 11.4.6 Key Developments.
- 11.5 Bruker Corporation.
- 11.5.1 Key Facts.
- 11.5.2 Business Description.
- 11.5.3 Products and Services.
- 11.5.4 Financial Overview..
- 11.5.5 SWOT Analysis.
- 11.5.6 Key Developments.
- 11.6 Quest Diagnostics Incorporated.
- 11.6.1 Key Facts.
- 11.6.2 Business Description.
- 11.6.3 Products and Services.
- 11.6.4 Financial Overview..
- 11.6.5 SWOT Analysis.
- 11.6.6 Key Developments.
- 11.7 Volitionrx Limited.
- 11.7.1 Key Facts.
- 11.7.2 Business Description.
- 11.7.3 Products and Services.
- 11.7.4 Financial Overview..
- 11.7.5 SWOT Analysis.
- 11.7.6 Key Developments.
- 12. Appendix
- 12.1 About The Insight Partners.
- 12.2 Glossary of Terms.
- LIST OF TABLES
- Table 1. UAE Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
- Table 2. UAE Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
- Table 3. UAE Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
- Table 4. UAE Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 5. UAE Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 6. UAE Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
- Table 7. UAE: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
- Table 8. Saudi Arabia Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
- Table 9. Saudi Arabia Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
- Table 10. Saudi Arabia Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
- Table 11. Saudi Arabia Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 12. Saudi Arabia Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 13. Saudi Arabia Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
- Table 14. Saudi Arabia: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
- Table 15. South Africa Colorectal Cancer Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
- Table 16. South Africa Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
- Table 17. South Africa Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
- Table 18. South Africa Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 19. South Africa Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 20. South Africa Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
- Table 21. South Africa: Colorectal Cancer Market Revenue and Forecast To 2028, By End Users (US$ Million)
- Table 22. Rest of MEA: Colorectal Cancer Market Revenue and Forecasts To 2028, By Modality (US$ Million)
- Table 23. Rest of MEA: Colorectal Cancer Market, by Diagnosis Type – Revenue and Forecast to 2028 (US$ Million)
- Table 24. Rest of MEA: Colorectal Cancer Market, by Therapy Type – Revenue and Forecast to 2028 (US$ Million)
- Table 25. Rest of MEA: Colorectal Cancer Market, by Chemotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 26. Rest of MEA: Colorectal Cancer Market, by Immunotherapy – Revenue and Forecast to 2028 (US$ Million)
- Table 27. Rest of MEA: Colorectal Cancer Market, by Imaging Type – Revenue and Forecast to 2028 (US$ Million)
- Table 28. Rest of MEA: Colorectal Cancer Market Revenue and Forecasts To 2028, By End User (US$ Million)
- Table 29. Recent Organic Growth Strategies In The Colorectal Cancer Market
- Table 30. Recent Inorganic Growth Strategies In The Colorectal Cancer Market
- Table 31. Glossary of Terms, MEA Colorectal Cancer Market
- LIST OF FIGURES
- Figure 1. MEA Colorectal Cancer Market Segmentation.
- Figure 2. MEA Colorectal Cancer Segmentation, By Country.
- Figure 3. MEA Colorectal Cancer Market Overview..
- Figure 4. Diagnosis Type Segment Held Largest Share Of Modality Segment In MEA Colorectal Cancer Market
- Figure 5. UAE is Expected To Show Remarkable Growth During The Forecast Period.
- Figure 6. MEA Colorectal Cancer Market – PEST Analysis.
- Figure 7. Comparison of Branded Drugs and Generic Drugs.
- Figure 8. MEA Colorectal Cancer Market Impact Analysis of Drivers And Restraints.
- Figure 9. MEA Colorectal Cancer Market – Revenue Forecasts And Analysis – 2020- 2028.
- Figure 10. MEA Colorectal Cancer Market Revenue Share, by Modality 2022 & 2028 (%)
- Figure 11. MEA Diagnosis Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 12. MEA Immunohistochemistry: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 13. MEA Stool Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 14. MEA Flexible Sigmoidoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 15. MEA Colonoscopy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 16. MEA CEA Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 17. MEA Other Test: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 18. MEA Therapy Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 19. MEA Chemotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 20. Alkylating Agent: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 21. MEA Antimetabolites: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 22. MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 23. MEA Immunotherapy: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 24. MEA Panitumumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 25. MEA Cetuximab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 26. MEA Bevacizumab: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 27. MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 28. MEA Chemoprotectant: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 29. MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 30. MEA Imaging Type: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 31. Computed Tomography (CT): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 32. MEA Magnetic Resonance Imaging (MRI): Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 33. MEA Others: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 34. MEA Colorectal Cancer Market Revenue Share, by End User 2022 & 2028 (%)
- Figure 35. MEA Hospitals: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 36. MEA Diagnostic and Research Laboratories: Colorectal Cancer Market – Revenue and Forecast to 2028 (US$ Million)
- Figure 37. MEA: Colorectal Cancer Market Revenue Overview, By Key Country – Revenue (2022) (US$ Million)
- Figure 38. MEA Colorectal Cancer Market Revenue and Forecasts to 2028, By Country (%)
- Figure 39. UAE Colorectal Cancer Market Revenue And Forecasts To 2028 (US$ Million)
- Figure 40. Saudi Arabia Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)
- Figure 41. South Africa Colorectal Cancer Market Revenue and Forecasts To 2028 (US$ Million)
- Figure 42. Rest of MEA: Colorectal Cancer Market Revenue and Forecasts to 2028 (US$ Million)
- Figure 43. Growth Strategies In The Colorectal Cancer Market, 2022-2028.
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook